Why Attend?

Preliminary Agenda
CLE

FDLI is excited to provide the key industry updates and the opportunity to connect with the food and drug law community that you have come to expect from the Annual Conference in a virtual format. While we will miss seeing each other in person, a virtual format allows the whole food and drug law community to participate regardless of safety concerns, location, time zone, or budget constraints.  

The Annual Conference will host an array of experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, and academia over the span of three shortened days to address the latest trends and updates in complex legal, regulatory, compliance, and policy issues currently impacting all facets of FDA-regulated industry.

Conference Highlights:

  • Hear FDA’s strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency and the impacts of COVID-19 as we move through 2021
  • Gain in-depth knowledge of each FDA Center by attending consecutive Center Director sessions scheduled to maximize attendee participation
  • Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding in the post-COVID era
  • Select from over 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals

Key FDA Speakers:

  • Janet Woodcock, Acting Commissioner, FDA
  • Mark Raza, Acting Chief Counsel, FDA
  • Patrizia Cavazzoni, Acting Director, Center for Drug Evaluation and Research, FDA
  • Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA 
  • Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA 
  • Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA
  • Steven M. Solomon, Director, Center for Veterinary Medicine, FDA
  • Mitchell R. Zeller, Director, Center for Tobacco Products, FDA
  • Additional FDA speakers pending

Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this winter. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in early March.

Register

 

Industry & Firms

$299
  • +$100 for non-members

Non-Profit

$299
  • +$100 for non-members

Government

$299
  • +$100 for non-members

Academic

$299
  • +$100 for non-members

Student

$99
  • full time students only
REGISTER NOW

Does Your FDLI Membership Qualify You for a Complimentary or Discounted Registration?

Member manufacturers, suppliers and distributors with more than $1 billion in sales as well as member law firms get one complimentary registration as part of their annual membership dues. Member manufacturers, suppliers and distributors with less than $1 billion in sales get one registration at 50% off as part of their annual membership dues. To take advantage of these opportunities, please contact us.

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

 

Premier Sponsor

 

Diamond Sponsor

 

 

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

 

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

Silver Sponsor

 

Silver Sponsor

 

Bronze Sponsor

Bronze Sponsor

 

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Planning Committee

Wade Ackerman, Covington & Burling LLP
David J. Bloch, Medtronic
Jeffrey B. Chasnow, Pfizer, Inc.
Sandra B. Eskin, Pew Charitable Trusts
Todd Halpern, GlaxoSmithKline
Erika F. Lietzan, (Co-Chair), University of Missouri-Columbia School of Law
Eric N. Lindblom
, Georgetown University
Adora Ndu, BioMarin Pharmaceutical Inc.
Meredith Q. Olearchik, Campbell Soup Company
Beth G. Oliva, Fox Rothschild
Suzan Onel, Kleinfeld, Kaplan & Becker LLP
John M. Packman, DLA Piper LLP
Stuart M. Pape, (Co-Chair), Polsinelli
Veleka Peeples-Dyer, Baker McKenzie
Vernessa T. Pollard, McDermott Will & Emery
David C. Spangler, Consumer Healthcare Products Association
Marta L. Villaraga, Exponent, Inc.
Anne K. Walsh, Hyman, Phelps & McNamara, PC